首页|期刊导航|LabMed Discovery|Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis in children and adolescents:An open-label,randomized,multicenter phase Ⅲ trial
Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis in children and adolescents:An open-label,randomized,multicenter phase Ⅲ trial
Lu Xia Xu-hui Liu Miao Xu Ting Zhang Guo-zhi Wang Bao-dong Yuan Feng Li Guo-xi Chen Xi-rong Wu Yan Guo Ting Song A-dong Shen Tao Li Shui-hua Lu
LabMed Discovery2025,Vol.2Issue(2):P.1-6,6.
LabMed Discovery2025,Vol.2Issue(2):P.1-6,6.DOI:10.1016/j.lmd.2025.100072
Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis in children and adolescents:An open-label,randomized,multicenter phase Ⅲ trial
摘要
关键词
Tuberculosis(TB)/Tuberculosis infection(TBI)/Creation tuberculin skin test(C-TST)/Secreted antigenic target 6-kDa protein-culture/filtrate protein 10(ESAT6-CFP10)/Skin test/Serious adverse events(AEs)分类
医药卫生引用本文复制引用
Lu Xia,Xu-hui Liu,Miao Xu,Ting Zhang,Guo-zhi Wang,Bao-dong Yuan,Feng Li,Guo-xi Chen,Xi-rong Wu,Yan Guo,Ting Song,A-dong Shen,Tao Li,Shui-hua Lu..Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis in children and adolescents:An open-label,randomized,multicenter phase Ⅲ trial[J].LabMed Discovery,2025,2(2):P.1-6,6.基金项目
supported by Anhui Longcom Biologic Pharmacy Co.Ltd.,China ()
This study received grant support from the Clinical Research Project of Shanghai Public Health Clinical Center of China(No.KY-GW-2024-01) (No.KY-GW-2024-01)
research start-up funds for introduced talents of Shanghai Public Health Clinical Center of China(No.RCJJ2025-08). (No.RCJJ2025-08)